0000899243-19-019303.txt : 20190708
0000899243-19-019303.hdr.sgml : 20190708
20190708160519
ACCESSION NUMBER: 0000899243-19-019303
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190705
FILED AS OF DATE: 20190708
DATE AS OF CHANGE: 20190708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McCracken Joseph S
CENTRAL INDEX KEY: 0001632454
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32157
FILM NUMBER: 19945393
MAIL ADDRESS:
STREET 1: C/O NEXVET BIOPHARMA PLC
STREET 2: NATL INST, FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK
STATE: L2
ZIP: 00000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Savara Inc
CENTRAL INDEX KEY: 0001160308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841318182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 150
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 512-614-1848
MAIL ADDRESS:
STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 150
CITY: AUSTIN
STATE: TX
ZIP: 78746
FORMER COMPANY:
FORMER CONFORMED NAME: Mast Therapeutics, Inc.
DATE OF NAME CHANGE: 20130312
FORMER COMPANY:
FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030613
FORMER COMPANY:
FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010928
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-07-05
0
0001160308
Savara Inc
SVRA
0001632454
McCracken Joseph S
6836 BEE CAVE ROAD, BUILDING III
SUITE 200
AUSTIN
TX
78746
1
0
0
0
Common Stock
2019-07-05
4
M
0
21682
0.82
A
81548
D
Common Stock
2019-07-05
4
M
0
2930
0.82
A
84478
D
Common Stock
2019-07-05
4
M
0
5860
1.46
A
90338
D
Common Stock
2019-07-05
4
M
0
9034
1.76
A
99372
D
Stock Option (Right to Buy)
0.82
2019-07-05
4
M
0
21682
0.00
D
2023-11-27
Common Stock
21682
0
D
Stock Option (Right to Buy)
0.82
2019-07-05
4
M
0
2930
0.00
D
2024-07-24
Common Stock
2930
0
D
Stock Option (Right to Buy)
1.46
2019-07-05
4
M
0
5860
0.00
D
2025-12-15
Common Stock
5860
0
D
Stock Option (Right to Buy)
1.76
2019-07-05
4
M
0
9034
0.00
D
2026-12-15
Common Stock
9034
1807
D
The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on January 15, 2014.
The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on October 24, 2014.
The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 15, 2016.
The shares subject to the option vest and become exercisable in twelve equal quarterly installments beginning on March 15, 2017.
/s/ David Lowrance as attorney-in-fact for Joseph S. McCracken
2019-07-08